BIOCRYST PHARMACEUTICALS INC Uncategorized Contracts & Agreements

75 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
BioCryst Pharmaceuticals, Inc. Inducement Equity Incentive Plan (Amended and Restated as of October 26, 2023)
Bonus & Incentive Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2023
BioCryst Pharmaceuticals, Inc. Inducement Equity Incentive Plan Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2023
First Amendment to Amended and Restated Employment Agreement between BioCryst Pharmaceuticals, Inc. and Dr. William Sheridan
Employment Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
Amendment Number Two to Credit Agreement among BioCryst Pharmaceuticals, Inc., Guarantors, Lenders, and Athyrium Opportunities III Co-Invest 1 LP
Credit Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
Waiver Agreement Relating to BCX9930 Clinical Hold – BioCryst Pharmaceuticals, Inc. and Lenders
Waiver Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
Amendment, dated August 10, 2022, to the Contract dated September 1, 2018 between BioCryst Pharmaceuticals, Inc. and the Department of Health and Human Services
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
Cash and cash equivalents
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
BioCryst Pharmaceuticals, Inc. Non-Employee Director Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2022
BioCryst Pharmaceuticals, Inc. Non-Employee Director Stock Option Agreement
Stock Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2022
EX-10.76 EX-10.101 EX-10.102 EX-10.103 EX-10.104 EX-21 EX-23 EX-31.1 EX-31.2 EX-32.1 EX-32.2 EX-101 EX-104
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
EX-10.72 EX-10.76 EX-10.101 EX-10.102 EX-10.103 EX-10.104 EX-21 EX-23 EX-31.1 EX-31.2 EX-32.1 EX-32.2 EX-101 EX-104
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
BioCryst Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement under Stock Incentive Plan
Bonus & Incentive Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2022
Amendment, dated August 27, 2021, to the Contract dated September 1, 2018 between BioCryst Pharmaceuticals, Inc. and the Department of Health and Human Services
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
Amendment, dated August 31, 2020, to the Contract dated September 1, 2018 between BioCryst Pharmaceuticals, Inc. and the Department of Health and Human Services
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2020
BioCryst Pharmaceuticals, Inc. Inducement Equity Incentive Plan (Amended and Restated as of February 7, 2020)
Bonus & Incentive Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2020
BioCryst Pharmaceuticals Employment Agreement with Anthony Doyle as Senior Vice President & CFO
Employment Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2020
Commercialization and License Agreement between BioCryst Pharmaceuticals, Inc. and Torii Pharmaceutical Co., Ltd. (November 5, 2019)
License Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2020
Separation and Release Agreement between Thomas R. Staab II and BioCryst Pharmaceuticals, Inc.
Separation Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2020
Second Amendment to Second Amended and Restated Credit and Security Agreement by and among BioCryst Pharmaceuticals, Inc., MDCP, LLC, and MidCap Financial Trust
Credit Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2019
First Amendment to Second Amended and Restated Credit and Security Agreement by and among BioCryst Pharmaceuticals, Inc., MDCP, LLC, and MidCap Financial Trust
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2019
Amendment dated as of September 23, 2019 to the Contract dated September 1, 2018 between BioCryst Pharmaceuticals, Inc. and the Department of Health and Human Services
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2019
BioCryst Pharmaceuticals Chief Business Officer Employment Agreement with Megan Sniecinski (May 31, 2019)
Employment Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2019
Second Amended and Restated Credit and Security Agreement among MidCap Financial Trust, Lenders, and BioCryst Pharmaceuticals, Inc.
Credit Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
MD
2019
Amended and Restated Credit and Security Agreement among MidCap Financial Trust, BioCryst Pharmaceuticals, Inc., MDCP, LLC, and Lenders (July 20, 2018)
Credit Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
MD
2018
Modification No. 22 to Contract No. IIllSN272201300017C Increasing Estimated Cost for Option 10
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2018
Financial Statements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2018
Amendment No. 0010 to Contract HHSO100201500007C between ASPR-BARDA and BioCryst Pharmaceuticals, Inc.
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2018
Supply Agreement for Peramivir (RAPIVAB) Between BioCryst Pharmaceuticals and the Centers for Disease Control and Prevention
Supply Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2018
Cash and cash equivalents
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2018
Cash and cash equivalents
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2017
Amendment No. 19 to Contract HHSN272201300017C between National Institutes of Health and BioCryst Pharmaceuticals, Inc.
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2016
Statement of Work between BioCryst Pharmaceuticals and HHS for BCX4430 NDA-Enabling CMC and Non-Clinical Toxicology Studies
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2016
Statement of Work for BCX4430 NDA-Enabling CMC and Non-Clinical Toxicology Studies between BARDA and Contractor
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2015
Novation Agreement among Albert Einstein College of Medicine, BioCryst Pharmaceuticals, Callaghan Innovation Research, and Victoria Link Limited
Assignment Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2015
Milestone and Deliverables Chart for HHSO100201500007C Clinical Trial Material Manufacturing and Development
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2015
Cash and cash equivalents
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014
Cash and cash equivalents
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014
Cash and cash equivalents
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014
Cash and cash equivalents
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014
Amendment No. 1 to Contract HHSN272201300017C between National Institutes of Health and BioCryst Pharmaceuticals, Inc.
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014